Problem-solving articles |
Akimkin V.G., Bormashov A.V.
Problems in medical waste disposal in the Russian Federation: State-of-the-art and solution prospects
|
4-9 |
Epidemic situation |
Vorobyev M.V.
The epidemic situation associated with the prevalence of toxicomania in the Russian Federation in 2000-2011
|
10-12 |
Punga V.V., Rusakova L.N., Yakimova M.A., Putova E.V., Izmailova T.V., Erokhin V.V.
Tuberculosis situation monitoring in the Russian areas supervised by the Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences
|
13-16 |
Original investigations |
Kovaleva T.A., Chuikova K.I.
Study of viral load and immune parameters in women with chronic HBV infection in the third trimester of pregnancy
|
17-22 |
Kaliaskarova K.S., Tuganbekova S.K., Kuzembaeva K.U., Konysbekova A.A., Malova E.S., Glazkova E.Ya., Balmasova I.P., Rybkina A.A., Bunkova E.B., Morozov V.G.
Genotypic profile and dynamics of viral load in patients with chronic hepatitis C during standard antiviral therapy in the representatives of Kazakh and Slavic populations in the Republic of Kazakhstan
|
23-28 |
Fazylov V.Kh., Chulanov V.P., Manapova E.R., Karandashova I.V., Dolgin V.A., Beshimov A.T.
Determination of interleukin-28B gene polymorphic variants in patients with mixed CHC/HIV infection
|
29-32 |
Nagoev B.S., Marjokhova A.R.
Time course of changes in some indicators of endogenous intoxication in erysipelas
|
33-39 |
Pomogaeva A.P., Nosareva O.L., Zhavoronok T.V.
Lipid peroxidation and nonenzymatic antioxidative system in children with pseudotuberculosis
|
40-44 |
Reviews and lectures |
Kostinov M.P., Andreeva N.P., Petrova T.I.
Clinical and epidemiological efficiency of the prevention of pneumococcal infection with vaccine in infants
|
45-52 |
Exchange of experience |
Ferrante S.A., Elbasha E.H.
Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Russia
|
53-63 |
Konstantinov D.Yu., Konstantinova E.A., Popova L.L., Strebkova E.A., Suzdaltsev A.A.
New approaches to optimizing antiviral therapy in patients with chronic hepatitis C and low baseline leukocyte content
|
64-67 |
Pyadushkina E.A., Andreeva N.S., Omelyanovsky V.V., Avxentyeva M.V., Rebrova O.Yu.
Сlinicoeconomic analysis of the use of kivexa in the first-line antiretroviral therapy of HIV infection in the Russian Federation
|
68-79 |
Book reviews |
Pokrovsky V.I.
V.V. Shkarin, O.V. Kovalishena. Emerging infections: Systematization, problems, prospects
|
80 |